- Home
- ISPC vs MTNB Comparison
ISPC vs MTNB Comparison
Compare ISPC & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- MTNB
- Stock Information
- Founded
- ISPC 2009
- MTNB 2013
- Country
- ISPC United States
- MTNB United States
- Employees
- ISPC N/A
- MTNB N/A
- Industry
- ISPC Precision Instruments
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- ISPC Health Care
- MTNB Health Care
- Exchange
- ISPC Nasdaq
- MTNB Nasdaq
- Market Cap
- ISPC 3.1M
- MTNB 3.1M
- IPO Year
- ISPC 2021
- MTNB N/A
- Fundamental
- Price
- ISPC $1.25
- MTNB $0.67
- Analyst Decision
- ISPC
- MTNB Hold
- Analyst Count
- ISPC 0
- MTNB 1
- Target Price
- ISPC N/A
- MTNB N/A
- AVG Volume (30 Days)
- ISPC 141.2K
- MTNB 32.8K
- Earning Date
- ISPC 04-14-2025
- MTNB 04-15-2025
- Dividend Yield
- ISPC N/A
- MTNB N/A
- EPS Growth
- ISPC N/A
- MTNB N/A
- EPS
- ISPC N/A
- MTNB N/A
- Revenue
- ISPC $9,291,115.00
- MTNB N/A
- Revenue This Year
- ISPC $35.93
- MTNB N/A
- Revenue Next Year
- ISPC N/A
- MTNB N/A
- P/E Ratio
- ISPC N/A
- MTNB N/A
- Revenue Growth
- ISPC N/A
- MTNB N/A
- 52 Week Low
- ISPC $1.02
- MTNB $0.48
- 52 Week High
- ISPC $11.80
- MTNB $9.70
- Technical
- Relative Strength Index (RSI)
- ISPC 47.69
- MTNB 64.44
- Support Level
- ISPC $1.15
- MTNB $0.54
- Resistance Level
- ISPC $1.23
- MTNB $0.60
- Average True Range (ATR)
- ISPC 0.16
- MTNB 0.05
- MACD
- ISPC 0.02
- MTNB 0.01
- Stochastic Oscillator
- ISPC 28.67
- MTNB 100.00
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.